TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
DMAC

DiaMedica Therapeutics Inc

Healthcare · Biotechnology

7.60$ -2.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement DMAC
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0%
0.0%
100.0%
904.4%
547.8%
1,452.2%
-1,352.2%
0.0%
-1,130.8%
16.0%
-1,146.8%
-1,127.8%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?